Johnson & Johnson: latest news, analysis and trading updates | ESM Magazine

J&J Beats Profit Estimates But Cuts Forecast On Coronavirus Uncertainty

Johnson & Johnson beat analysts' estimates for first-quarter profit on higher sales of its cancer drugs and consumer products including Tylenol, wh...

Johnson & Johnson Announces Potential Coronavirus Vaccine

Johnson & Johnson has announced a $1 billion deal with the U.S. government to create enough manufacturing capacity for more than one billion doses...

Johnson & Johnson Forecasts Weak Annual Profit, Misses Revenue Estimates

Johnson & Johnson has forecast 2020 profit to fall below Wall Street estimates, adding that increased competition could somewhat limit growth in it...

J&J Says New Tests Show No Asbestos In Johnson's Baby Powder

Johnson & Johnson said on Tuesday that recent tests showed that Johnson's Baby Powder was free of asbestos, after US Food and Drug Administration i...

Big US Retailers Pull 22-Ounce J&J Baby Powder Off Shelves After Recall

Four major US retailers, including Walmart and Target Corp, are removing all 22-ounce bottles of Johnson & Johnson's baby powder from their stores,...

Johnson & Johnson Reports Q1 Sales Above Expectations

Johnson & Johnson beat quarterly profit estimates on Tuesday and raised its adjusted sales growth forecast for the year. The company said it exp...

Johnson & Johnson 2019 Revenue Forecast Misses Expectations

Johnson & Johnson on Tuesday forecast 2019 sales that fell short of analysts' estimates after reporting better-than- expected fourth-quarter profit...